Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma

American Journal of Pathology

Volumn 175, Issue 1, 2009, Pages 25-35

  Romesser, Paul B ^a   Perlman, David H ^a   Faller, Douglas V ^a   Costello, Catherine E ^a   McComb, Mark E ^a   Denis, Gerald V ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; LARGE CELL LYMPHOMA; MASS SPECTROMETRY; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 67650000236     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080707     Document Type: Article

References (69)

1. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, Ries LAG, Schrag D, Jamison PM, Jemal A, Wu XC, Friedman C, Harlan L, Warren J, Anderson RN, Pickle LW: Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005, 97:1407-1427
2. Ng AK: Diffuse large B cell lymphoma. Semin Radiat Oncol 2007, 17:169-175
3. Illidge T, Tolan S: Current treatment approaches for diffuse large B cell lymphoma. Leukemia Lymphoma 2008, 49:663-676
4. Alizadeh AA, Staudt LM: Genomic-scale gene expression profiling of normal and malignant immune cells. Curr Opin Immunol 2000, 12:219-225
5. Alizadeh AA, Eisen M, Davis RE, C Ma, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr., Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM: Distinct types of diffuse large-B cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511
6. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC, Golub TR: Diffuse large B cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002, 8:68-74
7. Staudt LM: Gene expression profiling of lymphoid malignancies. Annu Rev Med 2002, 53:303-318
8. Greenwald R, Tumang JR, Sinha A, Currier N, Cardiff RD, Rothstein TL, Faller DV, Denis GV: Eμ-BRD2 transgenic mice develop B cell lymphoma and leukemia. Blood 2004, 103:1475-1484
9. Lenburg M, Sinha S, Faller DV, Denis GV: Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis. J Biol Chem 2007, 282:4803-4811
10. Pearson K: On lines and planes of closest fit to systems of points in space. Philosoph Mag 1901, 2:559-572
11. Pollack JR: A perspective on DNA microarrays in pathology research and practice. Am J Pathol 2007, 171:375-385
12. Tan MH, Rogers CG, Cooper JT, Ditlev JA, Maatman TJ, Yang X, Furge KA, Teh BT: Gene expression profiling of renal cell carcinoma. Clin Cancer Res 2004, 10:6315S-6321S
13. Duggan BJ, McKnight JJ, Williamson KE, Loughrey M, O'Rourke D, Hamilton PW, Johnston SR, Schulman CC, Zlotta AR: The need to embrace molecular profiling of tumor cells in prostate and bladder cancer. Clin Cancer Res 2003, 9:1240-1247
14. Marguiles AG, Klimberg VS, Bhattacharrya S, Gaddy D, Suva LJ: Genomics and proteomics of bone cancer. Clin Cancer Res 2006, 12:6217s-6221s
15. Bhati R, Patterson C, Livasy CA, Fan C, Ketelsen D, Hu Z, Reynolds E, Tanner C, Moore DT, Gabrielli F, Perou CM, Klauber-DeMore N: Molecular characterization of human breast tumor vascular cells. Am J Pathol 2008, 172:1381-1390
16. Dhamoon AS, Kohn EC, Azad NS: The ongoing evolution of proteomics in malignancy. Drug Discov Today 2007, 12:700-708
17. Steuer R: on the analysis and interpretation of correlations in metabolomic data. Brief Bioinform 2006, 7:151-158
18. Aebersold R, Mann M: Mass spectrometry-based proteomics. Nature 2003, 422:198-207
19. Chen R, Pan S, Brentnall TA, Aebersold R: Proteomic profiling of pancreatic cancer for biomarker discovery. Mol Cell Proteom 2005, 4:523-533
20. Alfonso P, Catala M, Rico-Morales ML, Durante-Rodriguez G, Moro-Rodriguez E, Fernandez-Garcia H, Escribano JM, Alvarez-Fernandez E, Garcia-Poblete E: Proteomic analysis of lung biopsies: differential protein expression profile between peritumoral and tumoral tissue. Proteomics 2004, 4:442-447
21. Alexe G, Alexe S, Liotta LA, Petricoin E, Reiss M, Hammer PL: Ovarian cancer detection by logical analysis of proteomic data. Proteomics 2004, 4:766-783
22. Neubauer H, Fehm T, Schutz C, Speer R, Solomayer E, Schrattenholz A, Cahill MA, Kurek R: Proteomic expression profiling of breast cancer. Recent Results Cancer Res 2007, 176:89-120
23. Yates JR 3rd: Database searching using mass spectrometry data. Electrophoresis 1998, 19:893-900
24. Denis GV, McComb ME, Faller DV, Sinha A, Romesser PB, Costello CE: Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines. J Proteome Res 2006, 5:502-511
25. Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858
26. Park JI, Strock CJ, Ball DW, Nelkin BD: The Ras/Raf/MEK/Extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol Cell Biol 2003, 23:543-554
27. Jupe ER, Liu XT, Kiehlbauch JL, McClung JK, Dell'Orco RT: The 3′ untranslated region of prohibitin and cellular immortalization. Exp Cell Res 1996, 224:128-135
28. McClung JK, Jupe ER, Liu XT, Dell'Orco RT: Prohibitin: potential role in senescence Development, and tumor suppression. Exp Gerontol 1995, 30:99-124
29. Wang S, Nath N, Adlam M, Chellappan S: Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 1999, 18:3501-3510
30. KIP1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo. Mol Cell Biol 2006, 26:6170-6184
31. Mosser DD, Caron AW, Bourget L, Meriin AB, Sherman MY, Morimoto RI, Massie B: The chaperone function of hsp70 is required for protection against stress-induced apoptosis. Mol Cell Biol 2000, 20:7146-7159
32. Lee JH, Lee JY, Chang SH, Kang MJ, Kwon H: Effects of Ser2 and Tyr6 mutants of BAF53 on cell growth and p53-dependent transcription. Mol Cells 2005, 19:289-293
33. Kappes F, Scholten I, Richter N, Gruss C, Waldmann T: Functional domains of the ubiquitous chromatin protein DEK. Mol Cell Biol 2004, 24:6000-6010
34. Sitwala KV, Adams K, Markovitz DM: YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter. Oncogene 2002, 21:8862-8870
35. Martens JHA, Verlaan M, Kalkhoven E, Dorsman JC, Zantema A: Scaffold/Matrix attachment region elements interact with a p300-scaffold attachment factor A complex and are bound by acetylated nucleosomes. Mol Cell Biol 2002, 22:2598-2606
36. Moller P, Momburg F, Hofmann WJ, Matthaei-Maurer DU: Lack of vimentin occurring during intrafollicular stages of B cell development characterizes follicular center cell lymphomas. Blood 1988, 71:1033-1038
37. Wang Q, Song C, Li CH: Molecular perspectives on p97-VCP progress in understanding its structure and diverse biological functions. J Struct Biol 2003, 146:44-57
38. Colombo E, Bonetti P, Lazzerini Denchi E, Martinelli P, Zamponi R, Marine JC, Helin K, Falini B, Pelicci PG: Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol Cell Biol 2005, 25:8874-8886
39. Grisendi S, Pandolfi PP: NPM mutations in acute myelogenous leukemia. N Engl J Med 2005, 352:291-292
40. Feurstein N, Mond JJ: "Numatrin," a nuclear matrix protein associated with induction of proliferation in B lymphocytes. J Biol Chem 1987, 262:11389-11397
41. Mesaeli N, Phillipson C: Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells. Mol Biol Cell 2004, 15:1862-1870
42. cdc37 acting in concert with Hsp90 is required for RAF-1 function. Mol Cell Biol 1999, 19:1661-1672
43. Yamanashi Y, Okada M, Semba T, Yamori T, Umemori H, Tsunasawa S, Toyoshima K, Kitamura D, Watanabe T, Yamamoto T: Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B cell antigen receptor-mediated signaling. Proc Natl Acad Sci USA 1993, 90:3631-3635
44. Yanagihara C, Shinkai M, Kariya KI, Yamawaski-Kataoka Y, Hu CD, Masuda T, Kataoka T: Association of elongation factor 1α and ribosomal protein L3 with the proline-rich region of yeast adenylyl cyclase-associated protein CAP. Biochem Biophys Res Commun 1997, 232:503-507
45. Gass JN, Gifford NM, Brewer JW: Activation of an unfolded protein response during differentiation of antibody-secreting B cells. J Biol Chem 2002, 277:49047-49054
46. Dombrauckas JD, Santarsiero BD, Mesecar AD: Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 2005, 44:9417-9429
47. Moumen A, Masterson P, O'Connor MJ, Jackson SP: hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Cell 2005, 123:1065-1078
48. Bomsztyk K, Seuningen IV, Suzuki H, Denisenko O, Ostrowski J: Diverse molecular interactions of the hnRNP K protein. FEBS Lett 1997, 403:113-115
49. Saraswat M, Mrudula T, Kumar PU, Suneetha A, Rao TS, Srinivasulu M, Reddy B: Overexpression of aldose reductase in human cancer tissues. Med Sci Monitor 2006, 12:525-529
50. Tammali R, Ramana KV, Singhal SS, Awasthi S, Srivastava SK: Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells. Cancer Res 2006, 66:9705-9713
51. Mohammad RM, Hamdan MY, al-Katib A: Induced expression of alpha-enolase in differentiated diffuse large cell lymphoma. Enzyme Protein 1994-95, 48:37-44
52. KIP2 gene in the promoter region in lymphoid malignancies of B cell phenotype. Blood 2002, 100:2582-2577
53. Sanderson HS, Clarke PR: Cell Biology: ran, mitosis and the cancer connection. Current Biol 2006, 16:R466-R468
54. Li M, Zhai Q, Bharadwaj U, Wang H, Li F, Fisher WE, Chen C, Yao Q: Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 2006, 106:2284-2294
55. Gildea JJ, Seraj MJ, Oxford G, Harding Ma, Hampton GM, Moskaluk CA, Frierson HF, Conaway MR, Theodorescu D: RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 2002, 62:6418-6423
56. Wang W, Goswami S, Lapidus K, Wells AL, Wyckoff JB, Sahai E, Singer RH, Segall JE, Condeelis JS: Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 2004, 64:8585-8594
57. Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A, Goswami S, Bresnick A, Condeelis JS: The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 2006, 173:395-404
58. Lin YH, Park ZY, Lin D, Brahmbhatt AA, Rio MC, Yates JR, Klemke RL: Regulation of cell migration and survival by focal adhesion targeting of LASP-1. J Cell Biol 2004, 165:421-432
59. Corte VD, Impe KV, Bruyneel E, Boucherie C, Mareel M, Vandekerckhove J, Gettemans J: Increased importin-β-dependent nuclear import of the actin modulating protein CapG promotes cell invasion. J Cell Sci 2004, 117:5283-5292
60. Watari A, Takaki K, Higashiyama, Li Y, Satomi Y, Takao T, Tanemura A, Yamaguchi Y, Katayama I, Shimakage M, Miyashiro I, Takami K, Kodama K, Yutsudo M: Suppression of tumorigenicity, but not anchorage independence, of human cancer cells by new candidate tumor suppressor gene CapG. Oncogene 2005, 25:7373-7380
61. Krecic AM, Swanson MS: hnRNP complexes: composition, structure and function. Curr Opin Cell Biol 1999, 11:363-371
62. Gao C, Mi Z, Guo H, Wei J, Wai P, Kuo PC: A transcriptional repressor of osteopontin expression in the 4T1 murine breast cancer cell line. Biochem Biophys Res Commun 2004, 321:1010-1016
63. Yan-Sanders Y, Hammons GJ, Lyn-Cook BD: Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells. Cancer Lett 2002, 183:215-220
64. Xu Y, Sumter TF, Bhattacharya R, Tesfaye A, Fuchs EJ, Wood LJ, Huso DL, Resar LM: The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia. Cancer Res 2004, 64:3371-3375
65. Krynetski EY, Krynetskaia NF, Bianchi ME, Evans WE: A nuclear protein complex containing high mobility group proteins B1 and B2, heat shock cognate protein 70. ERp60, and glyceraldehyde-3-phosphate dehydrogenase is involved in the cytotoxic response to DNA modified by incorporation of anticancer nucleoside analogues Cancer Res 2003, 63:100-106
66. Phizicky E, Bastiaens PI, Zhu H, Snyder M, Fields S: Protein analysis on a proteomic scale. Nature 2003, 422:208-215
67. Hanash S: Disease proteomics. Nature 2003, 422:226-232
68. Rifai N, Gillette MA, Carr SA: Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nature Biotechnol 2006, 24:971-983
69. Timothy JL, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, Dooling D, Dunford-Shore BH, McGrath S, Hickenbotham M, Cook L, Abbott R, Larson DE, Koboldt DC, Pohl C, Smith S, Hawkins A, Abbott S, Locke D, Hillier LW, Miner T, Fulton L, Magrini V, Wylie T, Glasscock J, Conyers J, Sander N, Shi X, Osborne JR, Minx P, Gordon D, Chinwalla A, Zhao Y, Ries RE, Payton JE, Westervelt P, Tomasson MH, Watson M, Baty J, Ivanovich J, Heath S, Shannon WD, Nagarajan R, Walter MJ, Link DC, Graubert TA, DiPersio JF, Wilson RK: DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 2008, 456:66-72